A suggested enhancer of carcinogenesis in pancreatic cancer is receptors of advanced glycation end products (RAGE), where AGE/RAGE signaling induces inflammation and generates reactive species, activating NFκB along the way [37]. This evidence concerns the gene AGER and pancreatic neoplasm.